Jump to search

June 2021

Switching from Western diet to a balanced diet may reduce skin, joint inflammation

June 22, 2021

Diet rich in sugar and fat leads to disruption in the gut’s microbial culture and contributes to inflammatory skin diseases such as psoriasis. Research shows that switching to a more balanced diet restores the gut’s health and suppresses inflammation.

New grants awarded for projects to improve mental health for Californians

June 21, 2021

UC Davis' Behavioral Health Center of Excellence has awarded three seed grants to help support new research efforts aimed at improving mental health in California.

UC Davis Health scientist awarded Pew Scholarship to beat bacteria behind tuberculosis

June 18, 2021

Bennett Penn, assistant professor of infectious diseases and of medical microbiology and immunology, has been named a 2021 Pew Scholar in the Biomedical Sciences. He will receive funding over the next four years to investigate how bacteria causing tuberculosis build resistance to antibiotics.

UC Davis Clinical and Translational Science Center awarded 5-year grant renewal from NIH

June 17, 2021

The Clinical Translational Science Center (CTSC) received notice of its third NIH award renewal. The 5-year award, almost $33 million, provides critical funding to continue CTSC’s essential services for the UC Davis research community.

MIND Institute brain bank focused on autism, diversity, education and research

June 7, 2021

The new CENE Brain Bank, supported by the MIND Institute, aims to increase the diversity of brain tissue available for research about autism and other neurodevelopmental conditions. The project includes collection sites in Latin American countries.

Rapid whole genome sequencing leads to better outcomes for babies, lower medical costs

June 4, 2021

A study published today outlined the success of Project Baby Bear, a real-world quality improvement program designed to test the clinical and economic value of using rapid Whole Genome Sequencing to diagnose and guide treatment for infants with unexplained rare disease.

Most Californians unaware of law to prevent gun violence but would support using it

June 4, 2021

A new study shows that two-thirds of Californians don’t know about a law designed to prevent a person at risk of hurting themselves or others from possessing or purchasing firearms or ammunition. More than 80% of survey participants were supportive once they read about this law.

Researchers discover potential new approach to treating psoriatic joint inflammation

June 3, 2021

An international team of researchers, led by UC Davis Health, developed a new therapeutic approach to treating psoriatic arthritis, a chronic inflammatory disease affecting the joints.

May 2021

More work still needed to recruit, retain OB/GYN residents that reflect the diverse patient population they serve

May 26, 2021

To address health care disparities among minority women in obstetrics and gynecology, one approach is to increase diversity among health care providers to better reflect the patient population that they serve. But are medical residents within OB/GYN more diverse than other medical specialties?

A call to gynecologic surgeons to reduce excess opioid pills after hysterectomy

May 19, 2021

A UC Davis Health study urged gynecologic surgeons to prescribe the smallest effective opioid prescription after hysterectomy. Their study found that, on average, patients use only half of pills prescribed after the operation.

UC Davis MIND Institute to host inaugural stem cell, gene therapy conference

May 11, 2021

The UC Davis MIND Institute is now accepting abstracts for its first-ever Stem Cell and Gene Therapy for Neurodevelopmental Disorders Conference. The September event will feature both in-person and virtual options and will focus on the development of treatments for genetic disorders.

UC Davis Health now enrolling children ages 12-17 for Novavax coronavirus vaccine trial

May 7, 2021

UC Davis Health will soon launch a stage 3 clinical trial for a new coronavirus vaccine for children ages 12-17 with the National Institutes of Health (NIH) and Novavax. The two-year study aims to enroll 100 participants.

April 2021

Calibrating Lactoferrin protein in milk may boost learning and protect neurons

April 29, 2021

Lactoferrin is a glycoprotein found naturally in breast milk. A study by UC Davis Professor Fredric A. Troy II found that the lactoferrin concentration in the diet has significantly different impacts on learning, brain development and neuroprotection.

PsychLight sensor to enable discovery of new psychiatric drugs

April 28, 2021

UC Davis researchers develop PsychLight, a sensor that could be used in discovering new treatments for mental illness, in neuroscience research and to detect drugs of abuse.

Promising gene therapy for Duchenne muscular dystrophy

April 28, 2021

Clinical researchers at UC Davis Health are using an innovative gene therapy approach for Duchenne muscular dystrophy, which the lead physician hopes will be a transformational treatment for children with the disease.

Celebrating translational science researchers at UC Davis

April 23, 2021

During its 16th annual CTSC Scholar Symposium, UC Davis celebrated the graduation of its newest cohort of scholars who conduct innovative applied health research.

MIND Institute study of anxiety in children with autism now includes online treatment

April 20, 2021

The UC Davis MIND Institute is now offering online treatment as part of its clinical trial known as the STAAR study. The trial will compare the effectiveness of the medication sertraline and cognitive behavioral therapy in treating anxiety in children with autism.

New test to study language development in youth with Down syndrome

April 8, 2021

A team led by UC Davis Health researchers tested and validated a new set of procedures for collecting, measuring and analyzing the spoken language of youth with Down syndrome in a naturalistic setting.